With the aging global population, the relationship between older people and their residential environments is increasingly important. This relationship is based on the match between the individual characteristics of a person, their needs and expectations, and the characteristics of their environment. By creating access to various health improvement factors and exposure to various risk factors, the conditions under which an individual ages can be modified. This helps to accelerate or decelerate the process of incapacitation that individuals undergo as they age. This can also reduce or reinforce socio-spatial inequalities, which underlie the preponderant role of territory and spatial policies in the prevention and promotion of healthy aging. This chapters supports the process for developing the Decade of Healthy Ageing (2020 – 2030) aligned to the Sustainable Development Goals (SDG3).

Ongoing attention must be paid to these psychological dimensions for migrants and refugees, as well as further research, de-stigmatization, and education of governments and other stakeholders during the Compacts' implementation, review, and follow-up period, supporting SDG3.

Human health, in the coming decades (and already in some “front-running” regions), is in peril. Although some authorities warn that over-stating such risks can induce paralysis and despair, under-stating them will not generate the intense action that is required. The impact of climate change on the Earth system is now so significant that the next ice age will likely be delayed by at least 50,000 years [201]. If humans do not rapidly change their collective behavior, then this may be their most enduring legacy. It is hoped that this chapter makes a small contribution to SDG3.

The growth of predictive data analytics and the simultaneous growth in the availability of interoperable AI-enabled devices offer opportunities to mitigate healthcare disparities currently endemic in indigent, underrepresented, and underserved communities supporting SDG3.

With a pressing climate emergency and increasing interconnectedness, the need for action on health at a global level is greater than ever. Achieving Universal Health Coverage with a strong base in primary healthcare is essential. This must be accompanied by policies to address the socioeconomic and environmental determinants of ill health, supporting SDG3.

The Global Alliance for Genomics and Health (GA4GH) is an international standards development organization (SDO) focused on advancing human health and medicine through genomic data sharing and interoperability. Founded in 2013, the organization has evolved over time and has adapted to unexpected challenges in ways that we believe would be of interest to the broad biomedical community. In this chapter, we present our experiences to support others wishing to share data through global, community-driven standards supporting SDG3.

Racial and ethnic disparities among clinical trial participants is a long-standing issue demanding attention in the research community as advances in precision medicine increase. This exclusion from clinical trial enrollment has tangible consequences, preventing traditionally underserved populations from benefitting from health innovation and cutting-edge technologies. Aggregation of populations into a generalized treatment population lends to the evident healthcare inequities we see today and support SDG3

The Global Alliance for Genomics and Health (GA4GH) is an international standards development organization focused on advancing human health and medicine through genomic data sharing and interoperability. Founded in 2013, the organization has evolved over time and has adapted to unexpected challenges. Three themes have emerged as critical to the organization's success: (1) community needs must drive development; (2) agility is necessary to create global equity and opportunity; (3) developing an idea into a widely adopted standard requires multiple levels of consensus furthering SDG3.

An estimated 50 million people around the world currently live with Alzheimer's disease or other dementias, dementia being a collective term for progressive syndromes that affect various expressions of cognitive function, such as memory and emotional expression. Alzheimer’s disease accounts for the majority of cases (50 to 70%, varying by country, based on Alzheimer’s Disease International and World Health Organization figures).

This book chapter advances SDG #3 and #10 by focusing on polyphenols and flavonoids and their crucial role in decreasing AD symptoms. In addition, it highlights the neuroprotective role of various essential ingredients of plant extracts such as Icariside, Onjisaponin B, Asarones, Liquiritin, Tanshinone IIA (TIIA) and cryptotanshinone (CT), Ginsenoside Rg1, and n-Butylidenephthalide. The efficacy of green nanotechnology are also discussed.